Potential of immunotherapy for sarcoma

被引：3
|
作者：
Hoffman, Robert M. [1 ,2 ]
Singh, Arun S. [3 ]
Eilber, Fritz C. [4 ]
机构：
[1] AntiCancer Inc, 7917 Ostrow St, San Diego, CA 92111 USA
[2] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA
[3] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Div Surg Oncol, 10833 LeConte Ave,Room 54-140 CHS, Los Angeles, CA 90095 USA
来源：
CANCER | 2017年 / 123卷 / 09期
关键词：
SOFT-TISSUE SARCOMA; DENDRITIC CELLS; CANCER-IMMUNOTHERAPY; TRIAL; PHASE-2; OK-432;
D O I：
10.1002/cncr.30603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This editorial examines Miwa et al's article entitled Phase 1/2 Study of Immunotherapy With Dendritic Cells Pulsed With Autologous Tumor Lysate in Patients With Refractory Bone and Soft Tissue Sarcoma: A Safe Method for Inducing an Immunological Response but With Limited Effects on Clinical Outcomes, which appears in the current issue of Cancer. The state of the art of autologous cancer vaccines is briefly reviewed, and suggestions for improved immunological therapy for sarcomas are discussed. See also pages 1576-84.
引用
收藏
页码：1488 / 1489
页数：2
相关论文
共 50 条
  • [1] Potential for immunotherapy in soft tissue sarcoma
    Tseng, William W.
    Somaiah, Neeta
    Engleman, Edgar G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3117 - 3124
  • [2] Immunotherapy and Biomarkers in Sarcoma
    Dajsakdipon, Thanate
    Siripoon, Teerada
    Ngamphaiboon, Nuttapong
    Ativitavas, Touch
    Dejthevaporn, Thitiya
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (03) : 415 - 438
  • [3] The future of immunotherapy for sarcoma
    Tsukahara, Tomohide
    Emori, Makoto
    Murata, Kenji
    Mizushima, Emi
    Shibayama, Yuji
    Kubo, Terufumi
    Kanaseki, Takayuki
    Hirohashi, Yoshihiko
    Yamashita, Toshihiko
    Sato, Noriyuki
    Torigoe, Toshihiko
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (08) : 1049 - 1057
  • [4] Immunotherapy for synovial sarcoma
    Albert, Catherine M.
    Pollack, Seth
    AIMS MEDICAL SCIENCE, 2019, 6 (03): : 191 - 200
  • [5] Immunotherapy in soft-tissue sarcoma
    Ayodele, O.
    Razak, A. R. Abdul
    CURRENT ONCOLOGY, 2020, 27 : 17 - 23
  • [6] Immunotherapy and Biomarkers in Sarcoma
    Thanate Dajsakdipon
    Teerada Siripoon
    Nuttapong Ngamphaiboon
    Touch Ativitavas
    Thitiya Dejthevaporn
    Current Treatment Options in Oncology, 2022, 23 : 415 - 438
  • [7] Clinical markers of immunotherapy outcomes in advanced sarcoma
    Husain, Mariu
    Quiroga, Dionisia
    Kim, Han Gil
    Lenobel, Scott
    Xu, Menglin
    Iwenofu, Hans
    Chen, James L.
    Verschraegen, Claire
    Liebner, David
    Tinoco, Gabriel
    BMC CANCER, 2023, 23 (01)
  • [8] Dendritic cell immunotherapy in soft tissue sarcoma
    Indelicato, Daniel J.
    Finkelstein, Steven E.
    IMMUNOTHERAPY, 2012, 4 (10) : 1023 - 1029
  • [9] The Landscape of Immunotherapy for Retroperitoneal Sarcoma
    Gingrich, Alicia A.
    Nassif, Elise F.
    Roland, Christina L.
    Keung, Emily Z.
    CURRENT ONCOLOGY, 2023, 30 (02) : 2144 - 2158
  • [10] Immunotherapy and Radiotherapy Combinations for Sarcoma
    Zhang, Qian S.
    Hayes, John P.
    Gondi, Vinai
    Pollack, Seth M.
    SEMINARS IN RADIATION ONCOLOGY, 2024, 34 (02) : 229 - 242
12345